Basic Information
Basic information for SNHG17-284-25aa-3
Peptide Name SNHG17-284-25aa-3
Genome Position chr20:38421880-38421954[-]
Species Human
Peptide Sequence MEKVAGGARKAVFLWITLAGHLPRL
Peptide Length 25
Unique No (SNHG17-202-25aa-2,SNHG17-224-25aa-1,SNHG17-230-25aa-1,SNHG17-231-25aa-2,SNHG17-233-25aa-2,SNHG17-258-25aa-1,SNHG17-267-25aa-2,SNHG17-272-25aa-1,SNHG17-274-25aa-1,SNHG17-278-25aa-2,SNHG17-280-25aa-2)
Grand Average of Hydropathicity 0.484
Relative Molecular Mass 3167.7
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000196756;SNHG17
Transcript ID/Name ENST00000669405;SNHG17-284
Transcript Length 2119
Coding Ability 0.421
DNA Sequence Corresponding to Peptide ATGGAGAAAGTTGCAGGTGGGGCTAGGAAAGCTGTATTCCTGTGGATTACTCTAGCTGGTCATTTGCCCCGATTG
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :